Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database.
about
Medical management of epileptic seizures: challenges and solutionsComparative analysis of the treatment of chronic antipsychotic drugs on epileptic susceptibility in genetically epilepsy-prone rats.Antidepressant use and risk of epilepsy and seizures in people aged 20 to 64 years: cohort study using a primary care database.Clozapine prescribing in the UK: views and experience of consultant psychiatrists.Regioselective biotransformation of CNS drugs and its clinical impact on adverse drug reactions.Metabolic and toxicological considerations for obsessive-compulsive disorder drug therapy.Treating epilepsy in the setting of medical comorbidities.Seizure associated with clozapine: incidence, etiology, and management.Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain injury to optimize and facilitate clinical translation.Prognostic models for predicting posttraumatic seizures during acute hospitalization, and at 1 and 2 years following traumatic brain injury.The Impact of Psychoactive Drugs on Seizures and Antiepileptic Drugs.Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis.Seizures during antidepressant treatment in psychiatric inpatients--results from the transnational pharmacovigilance project "Arzneimittelsicherheit in der Psychiatrie" (AMSP) 1993-2008.Acetylcholinesterase inhibition reveals endogenous nicotinic modulation of glutamate inputs to CA1 stratum radiatum interneurons in hippocampal slices.Corneal kindled C57BL/6 mice exhibit saturated dentate gyrus long-term potentiation and associated memory deficits in the absence of overt neuron loss.Effects of Dorema ammoniacum Gum on Neuronal Epileptiform Activity-Induced by Pentylenetetrazole.Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.
P2860
Q26766413-630E55F8-3CB0-4E66-AF2E-15CA98202EC6Q27339093-024E27CD-C011-4C26-9955-D48F0C9C1F16Q35871895-ABDDEB82-BD72-41CB-AFA4-325522292742Q35906545-46F7F82C-F3FA-4608-89BF-F524F64D7045Q38008438-C1608387-8B90-4668-A32A-014EDE4EF491Q38092129-DC4483C7-B59F-445D-ADEE-92877E59A8F9Q38214818-5B4EE3B5-EB89-4F98-BB47-DCD6AE6423CBQ38299304-97051D49-0444-4D84-AE87-C291D9156B4BQ38747752-EEDE3C88-D3D9-4FB4-9C26-1C4D906BC1B9Q38840437-BC1757F2-0E55-4BE9-9D17-F5D74AED4AC5Q38868459-71FED3B4-346C-4F8B-B512-E9E6F6EC44BDQ40660915-17605A61-DD43-4894-9494-0494FE18209BQ43800445-BE6F47DD-02CA-465B-B439-6214D38B046DQ45920192-E71A4857-23BA-4D3E-A073-C0C88C164D85Q50579165-F782ECC3-7A69-4356-8E1E-565106CAB3EAQ55082462-AFBA55C5-ADB5-4512-AF98-011EB3A0DD83Q55232340-A6BFDAC1-F0ED-4AC6-9F07-261ADB740F4D
P2860
Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Seizure risk associated with n ...... verse drug reactions database.
@ast
Seizure risk associated with n ...... verse drug reactions database.
@en
Seizure risk associated with n ...... verse drug reactions database.
@nl
type
label
Seizure risk associated with n ...... verse drug reactions database.
@ast
Seizure risk associated with n ...... verse drug reactions database.
@en
Seizure risk associated with n ...... verse drug reactions database.
@nl
prefLabel
Seizure risk associated with n ...... verse drug reactions database.
@ast
Seizure risk associated with n ...... verse drug reactions database.
@en
Seizure risk associated with n ...... verse drug reactions database.
@nl
P1476
Seizure risk associated with n ...... verse drug reactions database.
@en
P2093
Per Olov Lundberg
P356
10.1016/J.SEIZURE.2009.11.005
P50
P577
2009-12-24T00:00:00Z